New Hodgkin's Protocol: Brentuximab Vedotin and NivolumabNew Hodgkin's Protocol: Brentuximab Vedotin and Nivolumab
The new treatment protocol may advance the goal of phasing out the use of nonspecific, cytotoxic chemotherapy as a treatment for this disease. Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 26, 2016 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Lymphoma Survivors May Not Get All Recommended Follow-Up Care
California study finds gaps in after-care for teen and young adult Hodgkin disease survivors (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - January 15, 2016 Category: Cancer & Oncology Authors: webmaster at doctorslounge.com Tags: Family Medicine, Nursing, Oncology, Pediatrics, News, Source Type: news

Lymphoma Survivors May Not Get All Recommended Follow-Up Care
California study finds gaps in after-care for teen and young adult Hodgkin disease survivorsSource: HealthDay Related MedlinePlus Pages: Cancer--Living with Cancer, Lymphoma (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - January 15, 2016 Category: Consumer Health News Source Type: news

Lymphoma Survivors May Not Get All Recommended Follow-Up Care
California study finds gaps in after-care for teen and young adult Hodgkin disease survivors (Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - January 15, 2016 Category: Cancer & Oncology Source Type: news

Christmas, Grief, and Moving Forward After an Alzheimer's Diagnosis
The last time my mother and I stood near a Christmas tree together was December 2012. She was in the middle of a long battle with Chronic Lyme Disease and we had recently found out that she also had Alzheimer's. This dynamic cocktail of ailments left her unable to function as she used to -- as an entertainer, caregiver, and a joker. My mother and I were very close, and when she began showing signs of her disease I became extremely protective of her. A little more than 10 years prior my mother was very protective of me as I successfully battled Stage 3 Hodgkin's Disease -- cancer. This created a unique bond that seems to ...
Source: Healthy Living - The Huffington Post - December 25, 2015 Category: Consumer Health News Source Type: news

Autoimmune Disease Threatens Childhood Ca Survivors (CME/CE)
(MedPage Today) -- 1.4-fold increased risk especially after leukemia, Hodgkins lymphoma (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - November 13, 2015 Category: Hematology Source Type: news

Bacterium that causes Q fever linked to non-Hodgkin lymphoma
The bacterium that causes Q fever, an infectious disease that humans contract from animals, is associated with an increased risk of lymphoma, according to a study. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - October 13, 2015 Category: Science Source Type: news

Study: Bacterium that causes Q fever linked to non-Hodgkin lymphoma
(American Society of Hematology) The bacterium that causes Q fever, an infectious disease that humans contract from animals, is associated with an increased risk of lymphoma, according to a study published online today in Blood, the Journal of the American Society of Hematology. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - October 13, 2015 Category: Biology Source Type: news

Armed malaria protein found to kill cancer cells
(The Centre for Drug Research and Development) In models of non-Hodgkin's lymphoma, castration-resistant prostate cancer, and metastatic breast cancer, the Kairos-VAR2 therapeutic demonstrated the ability to prevent tumor growth, regress established tumors, and cure metastatic disease. The studies were published today in the journal Cancer Cell. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 13, 2015 Category: Cancer & Oncology Source Type: news

Second Cancers Are On The Rise
Second cancers are on the rise. Nearly 1 in 5 new cases in the U.S. now involves someone who has had the disease before. When doctors talk about second cancers, they mean a different tissue type or a different site, not a recurrence or spread of the original tumor. Judith Bernstein of suburban Philadelphia is an extreme example. She has had eight types over the last two decades, all treated successfully. “There was a while when I was getting one cancer diagnosis after another,” including breast, lung, esophageal, and the latest — a rare tumor of her eyelids, she said. “At one point I thought I had cance...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - August 24, 2015 Category: Consumer Health News Authors: miketoole Tags: Health Local News Cancer Source Type: news

Veterans Exposed To Toxic Chemicals Accuse VA Of Foot-Dragging
Retired Senior Master Sgt. Leslie Howe has battled two cancers -- non-Hodgkin lymphoma and prostate cancer, both of which have been linked with exposure to Agent Orange, the herbicide used by the U.S. military to destroy enemy cover and crops during the Vietnam War. Howe, 71, was never actually in Vietnam during the conflict, but in the 1980s he served aboard Air Force planes that contained trace amounts of the defoliant. Still, the U.S. Department of Veterans Affairs twice denied Howe's benefits claim, telling him in a letter that it "could not find a link" between his medical conditions and his military service. "I flew...
Source: Science - The Huffington Post - July 21, 2015 Category: Science Source Type: news

Teen With Cancer Uses Make-A-Wish To Share Story Of Sexual Abuse
    Considering the pain Lena Strickling has endured throughout her life, it would be understandable if she used her one Make-A-Wish to lounge on a remote, sandy beach far, far away. But Strickling, who has Hodgkin’s lymphoma and was sexually abused by her father, isn’t one for idling. Instead, the 18-year-old decided to use the opportunity to help empower young people who have undergone similar traumas. Strickling asked Make-A-Wish, a nonprofit that grants free experiences to children diagnosed with life-threatening diseases, to fund a video that would allow her to tell her story. She also inv...
Source: Healthy Living - The Huffington Post - July 15, 2015 Category: Consumer Health News Source Type: news

My Choice To Live: Part II
Last week, Jay Michael revealed his stage 4 cancer diagnosis in "My Choice to Live: Part I" on the Splash blog. Here, he continues his story... For most of my life, I have set lofty goals -- often very far-reaching goals that really pushed me to perform. My main goal in high school was to get the highest grades I could while doing as little work as possible -- admittedly, not an impressive goal. I made it my mission to find a way to move to London at 18, a city I was certain was my next hometown although I had never even been once; I celebrated my 18th birthday with a bunch of international students living in a breathtaki...
Source: Healthy Living - The Huffington Post - June 3, 2015 Category: Consumer Health News Source Type: news

Roche’s Gazyva/Gazyvaro extended the time people with refractory indolent non-Hodgkin’s lymphoma lived without their disease worsening
Roche today announced results from the Phase III GADOLIN study showing that Gazyva/Gazyvaro (obinutuzumab) plus bendamustine followed by Gazyva/Gazyvaro alone provided significant benefit for people with indolent non-Hodgkin’s lymphoma (NHL) that is refractory to MabThera/Rituxan (rituximab)-based treatment (Source: Roche Investor Update)
Source: Roche Investor Update - May 30, 2015 Category: Pharmaceuticals Source Type: news

Roche’s Gazyva/Gazyvaro extended the time people with refractory indolent non-Hodgkin’s lymphoma lived without their disease worsening
Roche today announced results from the Phase III GADOLIN study showing that Gazyva/Gazyvaro (obinutuzumab) plus bendamustine followed by Gazyva/Gazyvaro alone provided significant benefit for people with indolent non-Hodgkin’s lymphoma (NHL) that is refractory to MabThera/Rituxan (rituximab)-based treatment (Source: Roche Media News)
Source: Roche Media News - May 30, 2015 Category: Pharmaceuticals Source Type: news